Skip to main content

Table 1 The proposed combined evaluation Method

From: Predicting response to neo-adjuvant chemotherapy and assessment of residual disease in breast cancer using contrast-enhanced spectral mammography: a combined qualitative and quantitative approach

Type of Response

Tumor largest diameter

Intensity of enhancement

• Progressive disease

Increase

With or without change in the intensity

• Stable disease

No change in size

No change

• Poor response

< 30% decrease

Mild decrease in intensity

• Moderate response

30–60% decrease

And/or moderate to marked decrease in intensity of enhancement

• Marked response

> 60% decrease

Residual faint enhancement

• Complete Response

No residual lesion seen